The global Virus Filtration Market is estimated to be valued at US$ 5.08 Bn or Billion in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Virus filtration is a type of sterile filtration that is capable of removing viruses by trapping them on the surface of a membrane filter made of materials including nanofiltration or ultrafiltration membranes. Virus filtration is used in the manufacture of biological therapeutics including vaccines, blood, and plasma products to remove viruses from these materials and ensure the safety of the final product.
Market key trends:
With increasing disease outbreaks and epidemics and greater investment in vaccine development globally, the demand for virus removal filters to ensure the safety of vaccine products is growing rapidly. Filter manufacturers are developing new technologies and products tailored specifically for the vaccine market. Another key trend is the strong presence of contract service providers for virus removal steps during drug development and manufacturing. Leading filter manufacturers are partnering with these providers to ensure their products are widely available and accessible to drug developers.
Segment Analysis
The Global Virus Filtration Market Size is segmented into product, technique, application, and end user. By product, the market is classified into consumables and instruments. The consumables segment is expected to dominate the market as it requires recurrent purchases and is also involved in virus removal procedures. By technique, the market is bifurcated into filtration and chromatography. The filtration segment is predicted to hold a major share of the market as the filtration method removes viruses effectively from liquid products. By application, the market is divided into biologicals, medical devices, water purification, air purification, and others. The biologicals segment holds a significant share due to extensive R&D in biopharmaceuticals. By end user, the market is categorized into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Pharmaceutical & biotechnology companies are expected to lead the end-user segment owing to high adoption.
Key Takeaways
The global virus filtration market size is expected to witness high growth, exhibiting a CAGR of 14% over the forecast period, due to increasing R&D investments in the biopharmaceutical industry.
Regional analysis - North America dominates the market currently due to presence of global players and high adoption of virus filtration technology by biopharmaceutical companies in the region. Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to increasing outsourcing of pharmaceutical manufacturing to countries like China and India.
Key players - Key players operating in the virus filtration market are Wuxi Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck KgaA, Lonza Group Ltd., General Electric Company, Thermo Fischer Scientific Inc., Asahi Kasei Medical Co. Ltd., and Charles River Laboratories International Inc., among others. Wuxi Biologics and Sartorius AG hold major share of the market due to their extensive product portfolio and global presence.
Read Our More Blogs : https://www.rapidwebwire.com/virus-filtration-market-size-share-analysis-2023-2030/
Comments
0 comment